Contineum Therapeutics (CTNM) Assets Average (2024 - 2026)
Contineum Therapeutics (CTNM) posted quarterly Assets Average of $255.9 million for Q2 2026, up 34.26% year-over-year from $190.6 million in Q2 2025, and down 4.88% quarter-over-quarter from $269.0 million in Q1 2026.
Contineum Therapeutics (CTNM) Assets Average (2024 - 2026) Analysis & Trends
Contineum Therapeutics' Assets Average history runs 3 years deep, the most recent figure standing at $255.9 million for Q2 2026.
- In Q2 2026, Assets Average rose 34.26% year-over-year to $255.9 million; the TTM figure through Jun 2026 stood at $255.9 million (up 34.26% YoY), while the FY2025 annual figure was $244.7 million, up 42.61% from the prior year.
- Assets Average for Q2 2026 stood at $255.9 million, down from $269.0 million in the prior quarter.
- The five-year high for Assets Average was $269.0 million in Q1 2026, with the low at $127.0 million in Q1 2024.
- The 3-year median for Assets Average is $210.0 million (2024), against an average of $207.4 million.
- Peak annual rise in Assets Average reached 61.89% in 2025, while the deepest fall reached 14.55% in 2025.
- Contineum Therapeutics' Assets Average stood at $214.4 million in 2024, then climbed by 9.0% to $233.7 million in 2025, then rose by 9.46% to $255.9 million in 2026.
- Business Quant data shows CTNM's Assets Average at $255.9 million in Q2 2026, $269.0 million in Q1 2026, and $233.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Contineum Therapeutics | 533.73 Mn | 533.73 Mn | - | 255.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 255.86 Mn |
| Mar 31, 2026 | 269.00 Mn |
| Dec 31, 2025 | 233.74 Mn |
| Sep 30, 2025 | 186.87 Mn |
| Jun 30, 2025 | 190.58 Mn |
| Mar 31, 2025 | 205.56 Mn |
| Dec 31, 2024 | 214.44 Mn |
| Sep 30, 2024 | 218.69 Mn |
| Jun 30, 2024 | 172.46 Mn |
| Mar 31, 2024 | 126.98 Mn |